Literature DB >> 3170649

Cells with marrow and spleen repopulating ability and forming spleen colonies on day 16, 12, and 8 are sequentially ordered on the basis of increasing rhodamine 123 retention.

R E Ploemacher1, N H Brons.   

Abstract

Mouse bone marrow cells (BMC) were subjected to countercurrent centrifugal elutriation and subsequently separated on the basis of light scatter and fluorescence intensity after being labeled with the supravital dye Rhodamine 123 (Rh-123). The sorted cells were then assayed for their in vivo spleen colony-forming ability (day -8, -12, and -16 CFU-S) and their ability to repopulate the bone marrow or spleen over a 13-day period with CFU-S-12, CFU-GM, or nucleated cells. Cells with marrow repopulating ability (MRA), as measured by the ability of the sorted cells to repopulate the marrow with secondary CFU-S-12 or CFU-GM, had low affinity for Rh-123. These cells showed minimal spleen colony-forming ability, and the ratio of MRA to CFU-S-12 in this preparation was 309. Cells with spleen repopulating ability (SRA), CFU-S-16, CFU-S-12, and CFU-S-8 retained increasing amounts of Rh-123, respectively, and CFU-S-8 were almost exclusively found among cells with high Rh-123 affinity. These cells also included about half of all day-12 CFU-S, and the ratio of MRA to day-12 CFU-S was 0. The results show that MRA cells, SRA cells, CFU-S-16, CFU-S-12, and CFU-S-8 can be sequentially ordered on the basis of increasing mitochondrial activity. The data also demonstrate for the first time, and without the application of negative selection by the use of cytostatic agents, that MRA cells are a separate class of primitive hemopoietic stem cells that fully meet the criteria of pre-CFU-S.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3170649     DOI: 10.1002/jcp.1041360320

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Purification and characterization of retrovirally transduced hematopoietic stem cells.

Authors:  L M Spain; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Expression of cell cycle-related genes with cytokine-induced cell cycle progression of primitive hematopoietic stem cells.

Authors:  Peter J Quesenberry; Gerri J Dooner; Michael Del Tatto; Gerald A Colvin; Kevin Johnson; Mark S Dooner
Journal:  Stem Cells Dev       Date:  2010-04       Impact factor: 3.272

3.  Hematopoietic stem cells in research and clinical applications: The "CD34 issue".

Authors:  Zoran Ivanovic
Journal:  World J Stem Cells       Date:  2010-04-26       Impact factor: 5.326

4.  Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma.

Authors:  J Teixidó; M E Hemler; J S Greenberger; P Anklesaria
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

5.  The in vitro response of phenotypically defined mouse stem cells and myeloerythroid progenitors to single or multiple growth factors.

Authors:  S Heimfeld; S Hudak; I Weissman; D Rennick
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

6.  Genetic control of murine hematopoietic stem cell pool sizes and cycling kinetics.

Authors:  R L Phillips; A J Reinhart; G Van Zant
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

7.  Resting and activated subsets of mouse multipotent hematopoietic stem cells.

Authors:  G J Spangrude; G R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.